ES553685A0 - Un procedimiento para la produccion de un conjugado marcado con un trazador de metalotioneina y una molecula biologicamente activa - Google Patents

Un procedimiento para la produccion de un conjugado marcado con un trazador de metalotioneina y una molecula biologicamente activa

Info

Publication number
ES553685A0
ES553685A0 ES553685A ES553685A ES553685A0 ES 553685 A0 ES553685 A0 ES 553685A0 ES 553685 A ES553685 A ES 553685A ES 553685 A ES553685 A ES 553685A ES 553685 A0 ES553685 A0 ES 553685A0
Authority
ES
Spain
Prior art keywords
tracer
biologically active
metalotioneine
molecula
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES553685A
Other languages
English (en)
Other versions
ES8800437A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EIDP Inc
Original Assignee
EI Du Pont de Nemours and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by EI Du Pont de Nemours and Co filed Critical EI Du Pont de Nemours and Co
Publication of ES553685A0 publication Critical patent/ES553685A0/es
Publication of ES8800437A1 publication Critical patent/ES8800437A1/es
Expired legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/14—Peptides, e.g. proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Plant Pathology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Steroid Compounds (AREA)
ES553685A 1985-04-03 1986-04-03 Un procedimiento para la produccion de un conjugado marcado con un trazador de metalotioneina y una molecula biologicamente activa Expired ES8800437A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71943685A 1985-04-03 1985-04-03

Publications (2)

Publication Number Publication Date
ES553685A0 true ES553685A0 (es) 1987-10-16
ES8800437A1 ES8800437A1 (es) 1987-10-16

Family

ID=24890070

Family Applications (1)

Application Number Title Priority Date Filing Date
ES553685A Expired ES8800437A1 (es) 1985-04-03 1986-04-03 Un procedimiento para la produccion de un conjugado marcado con un trazador de metalotioneina y una molecula biologicamente activa

Country Status (15)

Country Link
EP (1) EP0196669B1 (es)
JP (1) JPS61236733A (es)
KR (1) KR930003312B1 (es)
AT (1) ATE72569T1 (es)
AU (1) AU603981B2 (es)
DE (1) DE3683861D1 (es)
DK (1) DK148586A (es)
ES (1) ES8800437A1 (es)
FI (1) FI861424A (es)
GR (1) GR860876B (es)
IE (1) IE58425B1 (es)
IL (1) IL78377A0 (es)
MX (1) MX168179B (es)
NO (1) NO167124C (es)
ZA (1) ZA862417B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4672028A (en) * 1984-05-23 1987-06-09 Icn Micromedic Systems, Inc. Compositions and method for simultaneous multiple array of analytes using radioisotope chelate labels
US5053493A (en) * 1987-04-02 1991-10-01 Centocor Cardiovascular Imaging Partners, L.P. Method for labeling antibodies with a metal ion
US5177192A (en) * 1987-04-02 1993-01-05 Centocor, Incorporated Method for labeling antibodies with a metal ion
US5218128A (en) * 1988-06-15 1993-06-08 Centocor, Inc. Bifunctional coupling agents and radionuclide labeled compositions prepared therefrom
US5759515A (en) * 1989-08-09 1998-06-02 Rhomed Incorporated Polyvalent peptide pharmaceutical applications
US5985240A (en) * 1989-08-09 1999-11-16 Rhomed Incorporated Peptide radiopharmaceutical applications
US5700444A (en) * 1992-02-20 1997-12-23 Rhomed Incorporated Chemotactic peptide pharmaceutical applications
US5219556A (en) * 1990-07-09 1993-06-15 Mallinckrodt Medical, Inc. Stabilized therapeutic radiopharmaceutical complexes
US5194594A (en) * 1990-09-07 1993-03-16 Techniclone, Inc. Modified antibodies
CA2048078A1 (en) * 1990-11-15 1992-05-16 Wolfgang A. Wrasidlo Chemical modification of antibodies for creation of immunoconjugates
DK0629133T3 (da) * 1992-01-03 2001-04-02 Rhomed Inc Farmaceutisk anvendelse af peptidmetalioner
US5738838A (en) * 1992-02-20 1998-04-14 Rhomed Incorporated IKVAV peptide radiopharmaceutical applications
US5556609A (en) * 1992-02-20 1996-09-17 Rhomed Incorporated YIGSR peptide radiopharmaceutical applications
CN1314966C (zh) * 2004-12-03 2007-05-09 湖南农业大学 一种猪金属硫蛋白的检测方法
JP5202443B2 (ja) * 2009-06-01 2013-06-05 興和株式会社 有害金属測定試薬及び測定方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4732864A (en) * 1983-10-06 1988-03-22 E. I. Du Pont De Nemours And Company Trace-labeled conjugates of metallothionein and target-seeking biologically active molecules
JP2871813B2 (ja) * 1990-07-03 1999-03-17 古河電気工業株式会社 クロスヘッドの角度調整装置

Also Published As

Publication number Publication date
GR860876B (en) 1986-07-29
DK148586A (da) 1986-10-04
KR930003312B1 (ko) 1993-04-26
KR860008203A (ko) 1986-11-12
NO167124C (no) 1991-10-09
MX168179B (es) 1993-05-10
AU603981B2 (en) 1990-12-06
FI861424A (fi) 1986-10-04
DK148586D0 (da) 1986-04-02
JPS61236733A (ja) 1986-10-22
DE3683861D1 (de) 1992-03-26
IL78377A0 (en) 1986-07-31
FI861424A0 (fi) 1986-04-02
ZA862417B (en) 1987-12-30
EP0196669A3 (en) 1988-09-14
ATE72569T1 (de) 1992-02-15
ES8800437A1 (es) 1987-10-16
NO167124B (no) 1991-07-01
IE860853L (en) 1986-10-03
IE58425B1 (en) 1993-09-22
NO861200L (no) 1986-10-06
EP0196669B1 (en) 1992-02-12
AU5552486A (en) 1986-10-09
EP0196669A2 (en) 1986-10-08

Similar Documents

Publication Publication Date Title
ES553685A0 (es) Un procedimiento para la produccion de un conjugado marcado con un trazador de metalotioneina y una molecula biologicamente activa
DE3582549D1 (de) Metallkomplexe, an die ein immunologisch aktives material gekoppelt werden kann bzw. ist, deren herstellung und verwendung.
BR8606644A (pt) Processo de formacao de um conjugado de proteina quelato metalico quelato metalico bifuncional,acido dietilenotriamina pentaacetico,composto precursor e processos de diagnostico"in vivo"e de tratamento de desordens celulares
MY101209A (en) Production of m-csf.
BG47033A3 (en) Method for preparing of derivatives of imidazolamine
NO854943L (no) Fremgangsmaate for fremstilling av en topisk, antibakteriell krem (salve).
ATE65491T1 (de) Verfahren zur herstellung von hochreinem 4,6diamino-1,3-benzoldiol.
FR2591892B1 (fr) Association collagene/principe actifantiseptique et/ou anti-inflammatoire a titre de composition, son procede de preparation et son utilisation pour la fabrication d'une composition pharmaceutique
ES2065906T3 (es) Produccion de proteinas en formas activas.
BG43692A3 (en) Method for preparing of 6, 16- dimethylcorticoids
ES536055A0 (es) Un procedimiento para la produccion de un complejo covalentemente enlazado de heparina-antitrombina-iii
DE3872228D1 (de) Elektrode fuer die entwicklung von sauerstoff und deren herstellungsverfahren.
BR9002428A (pt) Processo de preparacao de 1,1-dicloro-1-fluoroetano
HUP9801720A2 (hu) Új eljárás palatinit előállítására
PT80912B (pt) Processo de preparacao de derivados do lisergol
SU688262A1 (ru) Способ изготовлени полых цилиндрических изделий с утолщенной головкой
SU601232A2 (ru) Способ изготовлени изделий из стекла
ES2053857T3 (es) Un procedimiento para producir una cis-hidroxitrans-fenociclopentilamina.
SE8500708L (sv) Forfarande och form for framstellning av betong-tt-sadel-taksplattbalkar och -tt-parallellplattbalkar med anvendning av en och samma form
BG44707A3 (bg) Метод за получаване на 6-деметил-6-дезокси-6-метилен-5- окситетрациклин и негови 11а-хлорни производни
BE844404A (fr) Nouveaux derives d'acides (&-amino w-(methylenedioxy-2,3phenyl)acylamido)-6 penicillaniques, utiles notamment comme antibiotiques et preparation
KR960012580B1 (en) Transistor & method of manufacturing the same
ZA868404B (en) Pharmaceutical compositions for use in improving oxygenation of the brain and a process for their production
ATE62749T1 (de) Metallkomplexe, an die ein immunologisch aktives material gekoppelt werden kann bzw. ist, deren herstellung und verwendung.
HUT46848A (en) Process for producing pharmaceutical composition for topical application

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970612